Compare Stocks
Compare up to 5 stocks side by side with metrics, growth rates, and performance charts
Select Stocks
GNLX
OTLK
Add up to 3 more stocks
GNLX
Genelux Corporation
-2.25%
$2.54-0.06Delayed quote: Oct 6, 2026, 3:30 PM EDT
Market Cap
$113.97M
52W Range
$2.29 - $8.54
OTLK
Outlook Therapeutics, Inc.
-3.81%
$0.57-0.02Delayed quote: Oct 6, 2026, 3:30 PM EDT
Market Cap
$107.11M
52W Range
$0.16 - $2.54
| Metric | ||
|---|---|---|
| ValuationTTM multiples, at last close | ||
| P/E Ratio | N/A | N/A |
| Forward P/E | N/A | N/A |
| PEG Ratio | N/A | N/A |
| P/B Ratio | 7.07 | N/A |
| P/S Ratio | 14245.80 | N/A |
| P/FCF Ratio | N/A | N/A |
| EV/EBITDA | N/A | N/A |
| Profitabilitytrailing twelve months | ||
| Gross Margin | -7075.0% | 46.5% |
| Operating Margin | -415175.0% | -4744.3% |
| Net Margin | -422412.5% | -4416.2% |
| ROE | -209.7% | N/A |
| ROA | -129.0% | -233.4% |
| ROIC | -192.2% | -352.2% |
| Financial Healthlatest reported quarter | ||
| Current Ratio | 2.39 | 0.81 |
| Quick Ratio | 2.39 | 0.63 |
| Debt/Equity | 0.15 | N/A |
| Interest Coverage | N/A | -236.86 |
| Dividendstrailing dividends vs latest price | ||
| Dividend Yield | N/A | N/A |
| Payout Ratio | N/A | N/A |
| Yrs of Dividend Growth | 0 | 0 |
N/A includes missing data and metrics withheld while their applicability to the company is unverified. Bars show each value's size relative to the row's largest — a factual magnitude cue, not a rating. Tap a metric name for its full history.